Currently, there is evidence that immunohistochemical tests for p16INK4a expression can be a valuable supplementary marker for cervical cancer diagnosis as p16INK4a protein is over-expressed in most cases of cervical dysplasia and invasive squamous cell carcinoma [4]–[7]. This evidence concerns the gene CDKN2A and cervical carcinoma.